InvestorPlace Earnings

InvestorPlace Earnings

InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com.

Recent Articles

ETON Stock Earnings: Eton Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024

By InvestorPlace Earnings

ETON stock results show that Eton Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.

COLL Stock Earnings: Collegium Pharmaceutical Beats EPS, Beats Revenue for Q2 2024

By InvestorPlace Earnings

COLL stock results show that Collegium Pharmaceutical beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

CARG Stock Earnings: CarGurus Beats EPS, Beats Revenue for Q2 2024

By InvestorPlace Earnings

CARG stock results show that CarGurus beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

HHS Stock Earnings: Harte-Hanks Misses EPS, Misses Revenue for Q2 2024

By InvestorPlace Earnings

HHS stock results show that Harte-Hanks missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.

BLFS Stock Earnings: BioLife Solns Beats EPS, Beats Revenue for Q2 2024

By InvestorPlace Earnings

BLFS stock results show that BioLife Solns beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Load More